Doxorubicin

Links shared publicly online about this topic

Common Chemotherapy Drugs--Doxorubicin

suite101.com — “Doxorubicin is a frequently prescribed chemotherapy drug. As with any chemotherapy, however, patients should know its pros and cons before treatment.View full resource at suite101.com

  • View Related
  • Share

Most Recently Shared on October 28, 2010 at 1:25 am By:

HealthPassion HealthPassion Health News

Common Chemotherapy Drugs--Doxorubicin: Doxorubicin is a frequently prescribed chemotherapy drug. As with any chem... http://bit.ly/99jfjm

2 years ago...

Pegylated liposomal doxorubicin « Medical Search of the Day

medicalsearchoftheday.wordpress.com — “Pegylated liposomal doxorubicin « Medical Search of the DayView full resource at medicalsearchoftheday.wordpress.com

  • View Related
  • Share

Most Recently Shared on July 22, 2010 at 2:49 pm By:

searchmedica Lois Wingerson Health News

Pegylated liposomal doxorubicin: Yesterday this drug name was the top search term in SearchMedica (the source of a... http://bit.ly/9jKplN

2 years ago...

ingentaconnect Doxorubicin: Reversible dilated cardiomyopathy and cardioembolic ...

ingentaconnect.com — “ingentaconnect Doxorubicin: Reversible dilated cardiomyopathy and cardioembolic ...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on April 25, 2011 at 10:09 am By:

Stroke_Wisdom Stroke OW OW Health

Doxorubicin: Reversible dilated cardiomyopathy and cardioembolic stroke: case report: (Source: Reactions)MedWorm... http://bit.ly/dPz9QK

1 year ago...

ingentaconnect Cyclophosphamide/doxorubicin/methotrexate: Gastric emphysema: cas...

ingentaconnect.com — “ingentaconnect Cyclophosphamide/doxorubicin/methotrexate: Gastric emphysema: cas...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on November 10, 2010 at 7:55 am By:

Gastro_Digestiv OrganizedWisdom GI OW Health

Cyclophosphamide/doxorubicin/methotrexate: Gastric emphysema: case report: (Source: Reactions) http://bit.ly/b1MJVA

2 years ago...

IngentaConnect Cyclophosphamide/doxorubicin/paclitaxel: Amenorrhoea and more fre...

ingentaconnect.com — “IngentaConnect Cyclophosphamide/doxorubicin/paclitaxel: Amenorrhoea and more fre...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on June 29, 2010 at 11:35 am By:

Migraine_Wisdom Migraine OW OW Health

Cyclophosphamide/doxorubicin/paclitaxel: Amenorrhoea and more frequent migraines: case report: (Source: Reactions) http://bit.ly/9497tY

2 years ago...

IngentaConnect Cyclophosphamide/doxorubicin/paclitaxel: Pneumocystis carinii pne...

ingentaconnect.com — “IngentaConnect Cyclophosphamide/doxorubicin/paclitaxel: Pneumocystis carinii pne...View full resource at ingentaconnect.com

  • View Related
  • Share

Most Recently Shared on May 28, 2010 at 10:18 pm By:

Lung_Breathing Lungs and Breathing OW Health

Cyclophosphamide/doxorubicin/paclitaxel: Pneumocystis carinii pneumonia: case report: (Source: Reactions) http://bit.ly/9ZRtdk

2 years ago...

Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability - ONA

oncologynurseadvisor.com — “The combination of oxaliplatin and doxorubicin showed promising efficacy in either platinum-sensitive or platinum-resistant recurrent ovarian cancer, as reported by Ilya Pokateav, MD, from the Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, and colleagues at the American Society of Clinical Oncology’s 2011 Annual Meeting.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on June 5, 2011 at 5:23 pm By:

ONAcom OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher

Oxaliplatin + Doxorubicin in Recurrent Ovarian Cancer Shows Promise, Tolerability http://goo.gl/fb/ldXlW

12 months ago...

Johnson & Johnson Warns of Doxil (doxorubicin) Shortage - QualityPoint Technologies

qualitypointtech.net — “Johnson & Johnson has cautioned doctors not to start patients on therapy with its Doxil (doxorubicin Hcl liposome injection) because of shortages of the medicine made by an outside manufacturer. Reuters Health InformationView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 22, 2011 at 9:00 pm By:

MedicalFeed MedicalFeed Health News Feed

Johnson & Johnson Warns of Doxil (doxorubicin) Shortage: Johnson & Johnson has cautioned doctors not to start ... http://bit.ly/raOoxN

10 months ago...

For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin

medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard oView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2010 at 3:37 pm By:

medical_tweets medical_tweets Health News

For The Treatment Of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin De.. http://dld.bz/AcP7

1 year ago...

Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off-Patent Oncology Products

medicalnewstoday.com — “Pfizer Injectables, part of Pfizer Inc.'s (NYSE: PFE) Established Products Business Unit, announced the addition of doxorubicin hydrochloride injection, USP, to Pfizer Injectables' growing portfolView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 18, 2011 at 9:09 am By:

MedicalFeed MedicalFeed Health News Feed

Pfizer Injectables Adds Doxorubicin Hydrochloride Injection, USP To Its Portfolio Of Off… http://goo.gl/fb/tdfb8

11 months ago...

Cyclophosphamide and Doxorubicin or Paclitaxel in Treating Women With Breast Cancer | LocalClinicalTrials.com

localclinicaltrials.com — “Cyclophosphamide and doxorubicin or paclitaxel in treating women with breast cancer clinical trial at localclinicaltrials.com.View full resource at localclinicaltrials.com

  • View Related
  • Share

Most Recently Shared on December 31, 2009 at 7:59 am By:

menforacause Men For A Cause (TM) Health Organization

RT @baxtertrials: cyclophosphamide & doxorubicin or paclitaxel in treating women w/ breast cancer http://bit.ly/61ZNh0

2 years ago...

Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy " Ann Oncol

annonc.oxfordjournals.org — “Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy " Ann OncolView full resource at annonc.oxfordjournals.org

  • View Related
  • Share

Most Recently Shared on May 25, 2010 at 8:48 pm By:

SkinCancer_OW Skin Cancer OW OW Health

Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemo... http://bit.ly/c2DVW8

2 years ago...

Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells

content.karger.com — “Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer CellsView full resource at content.karger.com

  • View Related
  • Share

Most Recently Shared on January 26, 2011 at 6:21 pm By:

Urology_Wisdom Urology & Nephrology OW Health

Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherap... http://bit.ly/fGJSti

1 year ago...

Oncology News - Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells |3990466

mdlinx.com — “Oncology Medical Article: Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cellsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 11:22 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells: Molecular Cancer http://t.co/cQbI8XG6 #oncology

2 months ago...

Novel Agent Demonstrates Activity in Heavily Pretreated Ovarian Cancer That Progressed on Pegylated Doxorubicin

onclive.com — “A novel topoisomerase-I inhibitor designated NKTR-102 demonstrated clinically significant activity as a single agent in patients with heavily pretreated ovarian cancer who failed prior PLD.View full resource at onclive.com

  • View Related
  • Share

Most Recently Shared on August 1, 2011 at 2:29 pm By:

ONClive Editor Oncology

Novel Agent Demonstrates Activity in Heavily Pretreated Ovarian Cancer That Progressed on Pegylated Doxorubicin http://t.co/jz7fFD3

10 months ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • HealthPassion

    HealthPassion

    Follow your Health Passion Here! We will be feeding all Health News, Updates, Tips and Reviews. We hope to help you pursue and follow your Passion.

    View Profile

  • searchmedica

    Lois Wingerson

    Content manager for searchmedica.com, free authoritative medical search designed for and by doctors

    View Profile

  • Stroke_Wisdom

    Stroke OW

    Organizing stroke and mini-stroke resources shared by health experts, advocates, and organizations into WisdomCards.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390